BCMA/CD19 CAR T cell therapy for refractory myasthenia gravis: Proteomic signatures and single-cell transcriptomics of disease flares

Journal:

Science Advances

Published:

2026-01-02

DOI:

10.1126/sciadv.aeb6424

Affiliations:

10

Authors:

23

Go to article

Institutions	Authors	Share
Affiliated Hospital, XZMC, China	16.333333 16.333333	0.71
Xuzhou Medical University (XZMC), China	2.666667	0.12
The General Hospital, TMU, China	1.000000	0.04
Shijiazhuang People's Hospital, China	1.000000	0.04
KingMed Diagnostics, China	1.000000	0.04
Shanghai OE Biotech Co., Ltd., China	1.000000	0.04

Interested in Neurosciences?